News Quantified

GSK – gsk plc american depositary shares (each representing two ordinary shares) (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

GSK plc (NYSE: GSK) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $39.50 price target on the stock, down previously from $53.00.

GSK plc (NYSE: GSK) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy' [Seeking Alpha]

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons

Form SC 13G/A GSK plc Filed by: GSK plc

Form 6-K GSK plc For: Nov 12

Form 6-K GSK plc For: Nov 12

Form 6-K GSK plc For: Nov 01

Form 6-K GSK plc For: Oct 30

Top News Gainers

3/12 8 Best Pharmaceutical Stocks to Buy for Income [Yahoo! Finance News] 6.6%

3/3 GlaxoSmithKline Reportedly Trying Again to Sell Antibiotics Line [The Motley Fool] 5.1%

3/2 Form 6-K GLAXOSMITHKLINE PLC For: Mar 02 4.9%

4/16 UPDATE 2-'Too early' to lift UK lockdown but coronavirus outbreak peaking, minister says [Reuters] 3.7%

3/24 Form 6-K GLAXOSMITHKLINE PLC For: Mar 24 3.7%

7/24 REFILE-UPDATE 1-GSK predicts smaller fall in 2019 profit after standout quarter for Shingrix [Reuters] 2.5%

5/21 What Older Adults Need To Know About Measles And Shingles Vaccines [Forbes] 2.3%

7/19 Inside The Pharmaceutical Lobby's Campaign For More Government Subsidies Through Medicare Part D [Forbes] 2.2%

4/8 Gilead: Upside From Potential Coronavirus Treatment Could Dissipate [Seeking Alpha] 2.1%

6/6 Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options 2.1%

Top News Decliners

3/20 Form 6-K GLAXOSMITHKLINE PLC For: Mar 20 -3.9%

3/6 Form 20-F GLAXOSMITHKLINE PLC For: Dec 31 -3.9%

3/2 Here's Why Shares of AnaptysBio Jumped Today [The Motley Fool] -3.8%

4/15 UPDATE 1-The world will need more than one COVID-19 vaccine, GSK CEO says [Reuters] -3.2%

2/23 Better Buy: GlaxoSmithKline vs. Eli Lilly [The Motley Fool] -2.9%

10/1 GlaxoSmithKline (GSK) Presents At ESMO Congress 2019 - Slideshow [Seeking Alpha] -2.6%

2/5 GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.6%

4/28 Better Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline [The Motley Fool] -2.5%

5/13 Form 6-K GLAXOSMITHKLINE PLC For: May 13 -2.4%

5/7 UPDATE 1-UK Stocks-Factors to watch on May 7 [Reuters] -2.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day